Skip to content

Clinical trials

Phase 1/2 Small Cell Lung Carcinoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Country / region: Belgium Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20142
20151
20161
20171
20191
20221
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Recruiting2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
AbbVie1
Bristol-Myers Squibb1
Eli Lilly and Company1
G1 Therapeutics, Inc.1
Incyte Biosciences International Sàrl1
Incyte Corporation1
Ipsen1
MediLink Therapeutics (Suzhou) Co., Ltd.1
Salubris Biotherapeutics Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma11
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Carcinoma, Transitional Cell2
Colorectal Neoplasms2
Melanoma2
Neoplasm Metastasis2
Squamous Cell Carcinoma of Head and Neck2
Triple Negative Breast Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.